ACCESS: Medicare's Payment Pathway for Continuous AI-Driven Care | Cybernomics
policyWednesday, May 13, 2026

ACCESS: Medicare's Payment Pathway for Continuous AI-Driven Care

Medicare's ACCESS model creates the first clear reimbursement mechanism for AI agents that perform between-visit monitoring, coordination, and non-visit care tasks. This change unlocks commercial pathways for digital health tools that provide continuous, AI-assisted patient management outside traditional encounters.

ACCESS addresses a critical gap in healthcare economics: how to pay for the invisible work of remote monitoring, care coordination, and AI-driven interventions between appointments. Until now, billing structures rarely compensated for asynchronous activities such as automated check-ins, social determinant referrals, or adherence nudges. By defining reimbursement pathways for these functions, ACCESS makes it economically viable for providers and vendors to invest in AI agents that extend care beyond the clinic.

For digital health startups and healthcare systems, the impact goes beyond incremental revenue. Reimbursement legitimizes operational models that rely on continuous engagement and outcome-oriented interventions. Investors and buyers will be more willing to fund solutions that can show measurable reductions in readmissions, better medication adherence, or improved social needs resolution. That said, ACCESS also sets expectations for measurable outcomes and documentation-systems must capture and prove value to justify payment.

Healthcare leaders should act quickly to pilot AI-mediated workflows that map to ACCESS-eligible activities. Key steps include instrumenting measurement frameworks tied to clinical outcomes, ensuring interoperability with EHRs for documentation, and building data governance processes that satisfy HIPAA and Medicare auditability. Vendors should prepare evidence packages-clinical validation, cost-effectiveness analyses, and workflow integration plans-so they can partner with providers when reimbursement pathways are engaged.

Strategically, this policy shift signals broader acceptance of AI as a reimbursable clinical actor. Organizations that develop robust, audited, and outcome-oriented AI care flows now will gain first-mover advantages in an ecosystem moving toward value-based, technology-enabled care.

healthcarereimbursementpolicydigital-health

Original Source

TechCrunch

Read Original